Sigilon Therapeutics
Lilly and Sigilon team up in $473m+ deal to ‘cure’ diabetes
April 5, 2018Sales and Marketing Eli Lilly, Sigilon Therapeutics, biotech, drugs, pharma, pharmaceutical
Eli Lilly and Sigilon Therapeutics have announced a partnership that looks to break new ground in the management of type …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
